Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FeelGood vs OlleveCare

FeelGood
Graded #120

Higher grade

vs+23.299999999999997
OlleveCare
Graded #497

Lower grade

The verdict

FeelGood takes it — 69.5/100 to 46.2/100.

FeelGood grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Telehealth weight-loss program offering compounded GLP-1 medications (weekly injections and daily dissolvable tablets) plus limited brand-name options, prescribed by US-licensed providers and shipped to…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueFeelGood +35
80
45
Dose & formulationFeelGood +24
64
40
Clinical oversightFeelGood +26
79
53
Labs & monitoringFeelGood +4
53
49
FulfillmentFeelGood +33
71
38
Contract termsEven
55
55
FeelGood · left barOlleveCare · right bar

The numbers

MetricFeelGoodOlleveCare
WeighScore69.5/10046.2/100
GradeCC
Scorecard rank#120#497
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published13 states
Brand-name accessYesCompounded only
Oral / sublingualYesInjection only
FeelGood

Graded #120 · C

Strengths

  • Both compounded semaglutide (GLP-1) and tirzepatide (GLP-1 + GIP) formulations available
  • Low compounded injection entry price ($149/mo) with no membership or hidden fees
  • Oral/dissolvable tablet option for needle-averse patients
  • LegitScript-certified site (seal #247923); OpenLoop Health telehealth backbone
  • Free shipping and HSA/FSA eligibility

Where it loses points

  • State availability not publicly disclosed on the site
  • Compounding pharmacy partner not named publicly ("US-certified pharmacy" only)
  • Brand-name ("Original") injections are expensive at $1,999/mo and limited in availability
OlleveCare

Graded #497 · C

Strengths

  • 13 states listed explicitly (VA, FL, AZ, MA, HI, IA, MD, NM, WA, KS, NY, DC, ID)
  • Both semaglutide and tirzepatide offered — switch molecules without switching platforms
  • Multi-service platform — GLP-1, virtual urgent care, and non-controlled refills with one provider
  • Cash-pay with a superbill option for out-of-network reimbursement
  • Founder Ahmed Emam is named in the footer

Where it loses points

  • Legal entity name not disclosed anywhere — can't be verified in a state registry
  • Pricing not shown before booking — you must enter the intake flow to see the fee
  • Pharmacy partner not named; model appears to fill at your preferred retail pharmacy
  • No medical director or prescribing clinician named — only 'board-certified providers'
  • No LegitScript badge, BBB profile, or HIPAA/SOC 2 seals displayed

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard